This is a past event. Registration is closed. View other OBN events.
- Showcase Sponsors
Thermo Fisher Scientific
Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challengers, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Patheon and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services.
www.thermofisher.com/uk/en/home.html@company
PPD, part of Thermo Fisher Scientific, provides clinical development and analytical services that enhance customer innovation and productivity. Utilizing patient-centered strategies and data analytics, we cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, patient recruitment, investigator sites and comprehensive laboratory services.
Thermo Fisher Scientific also provides industry leading CDMO services as well as clinical trial solutions. With more than 55 locations around the world, we provide an end-to-end drug development offering to companies of all sizes that includes API, Biologics, Plasmids, Viral Vector Services, Early and Late Phase Development, Clinical Trial Solutions, Logistics Services and Commercial Manufacturing. Thermo Fisher is a trusted partner for every step in the drug development journey with unrivalled quality, reliability and expertise.
The Thermo Fisher Scientific team looks forward to returning to BioSeed as a Showcase Sponsor. We welcome the opportunity to meet with you during the event. To schedule a meeting, please contact Mark Beresford, Global Enterprise Relationship Lead.
For more information about Thermo Fisher Scientific, please visit www.thermofisher.com or email mark.beresford@thermofisher.com or call 07800 569628
BioInnovation Institute
The BioInnovation Institute Foundation (BII) is an international enterprise foundation with a non-profit objective incubating and accelerating world-class life science innovation that drives the development of new solutions by translational research projects and early-stage start-ups for the benefit of people and society.
bii.dk/@company
BII, located in Copenhagen, Denmark, offers start-ups and early-stage projects within health tech, therapeutics, and bioindustrials state-of-the-art labs, vibrant office facilities, business development, start-up business incubation, access to high-level mentoring and international networks, plus unique funding opportunities of up to 1.8 million euro per start-up and 3 million euro per project.
Since the inauguration of BII in November 2018, BII has awarded 59 million euros to 70 high-growth start-up companies. Read more on www.bioinnovationinstitute.com
WuXi App Tec (UK)
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2022 and its open-access platform is enabling more than 5,900 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated.
www.wuxiapptec.com/@company
Lonza
As a leader for contract development and manufacturing, Lonza is recognized for reliable, high-quality services, global capacity, innovative technology platform and extensive experience. We serve pharmaceutical and biotechnology companies globally striving to help reduce risk and increase chances of business success. Our broad capabilities span across biologics, small molecules, bioconjugates and cell and gene therapies; for projects ranging from pre-clinical stage through to commercialization, for both drug-substance and -product.
www.lonza.com@company
Discovery Park Ventures
Discovery Park Ventures is the investment fund of Discovery Park, one of the UKs largest science and innovation centres, located in Kent.
discovery-park.co.uk/discovery-park-ventures/@company
Investing on behalf of private individuals, the £1m fund supports ambitious and exciting early-stage life science companies at start-up or to help them leverage non-dilutive funding and has plans to expand to up to £25m in the next three years.
The fund invests in novel and disruptive technologies, usually related to Discovery Park’s areas of focus, such as advanced manufacturing, digital and AI, cell and gene therapies, synthetic biology and neurology (including ophthalmology). Investee companies will have a strong collaborative relationship with Discovery Park or may be a tenant.
- Industry Sponsor
Evotec
ABOUT EVOTEC SE
www.evotec.com@company
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this “Data-driven R&D Autobahn to Cures” for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases. Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development. Evotec operates globally with more than 4,500 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
For additional information please go to www.evotec.com and follow us on Twitter @Evotec and LinkedIn.
- Networking Drinks Sponsor
Medicilon
Medicilon is one of leading contract research organizations (CRO) with over 2,000 scientists to work over 1000 drug discovery companies and research projects for global clients from small novel drug research companies to the multinational pharmaceutical companies. We provide the integrated and comprehensive one-step new drug R&D for pharmaceutical enterprises and scientific research institutions around the world. Our 4 laboratories sites are over 81,600 sq.m. capacity to offer the fully integrated novel drug research services to help clients developing their research programs from the initial idea stage to the IND filing. The preclinical study laboratory is accredited AAALAC-certified animal research facility in compliance with US FDA GLP and China NMPA GLP standard. Our services cover the entire preclinical new drug research process, including drug discovery – Chemistry, Protein target verification, structural biology chemical synthesis, API; ADME, DMPK, Pharmacodynamics pharmacokinetics toxicology, and drug safety evaluation and IND filling full package.
www.medicilon.com/@company
- Lanyard Sponsor
Partners&
The Partners& science and technology insurance team is a highly specialist practice. We’re on hand to advise clients operating across the bioscience, R&D, clinical trials, medical device and technology sectors.
www.partnersand.com/@company
We take a holistic approach – helping you to identify and understand your current and emerging risks so you can make informed decisions.
From university spin-outs and start-ups to multinational companies, we’re here help you to as your enterprise grows and changes.
We will work with you to create an insurance and risk management programme to protect your business and your team, building resilience to the challenges you face.
And, if you need to make a claim, we’ll stand shoulder to shoulder with you, getting you back on your feet as soon as possible and supporting you through the next challenge.
With offices across the UK, including Oxford, London and Cambridge, our team is well placed to meet the needs of OBN members wherever you are located.
- Industry Exhibitors
Domainex
Domainex is a multi-award-winning integrated drug discovery research service partner, which provides the full range of pre-clinical drug discovery services. We work collaboratively in partnership with clients from a variety of sectors including academic, pharmaceutical, biotechnology and patient foundation organisations around the world. Our team comprises of over 90 scientists, who are committed to providing high quality services, and have expertise in:
www.domainex.co.uk/@company
• Protein production and characterisation
• Structural biology (X-ray crystallography and cryo-EM)
• Assay development and screening (biochemical, biophysical and cell assays)
• High-throughput screening (HTS)
• Computational chemistry including virtual screening
• Medicinal, synthetic and analytical chemistry
• Fragment- and structure-based drug discovery
We have an excellent reputation and >80% of our clients sign up for extensions or additional studies.
Dalriada Drug Discovery
Dalriada Drug Discovery is a fully integrated small molecule drug discovery CRO located in Toronto, Canada, supporting global biotech and pharma innovators through its TURN-KEY™ model, where R&D is perfectly aligned with business support and IP management. Dalriada’s team is high on experience and capability and has been fully integrated from day one. The product of this can be seen in our strong performance & track record, and in our roster of happy clients.
www.dalriadatx.com/@company
This year Dalriada turned five. That’s five years of driving innovative small-molecule programs from concept to IND. Over that time, our team and our capabilities have significantly grown, and we now offer global clients a wide breadth of top-notch drug discovery services that include, medicinal chemistry, ADME, biological sciences, proteomics, structural biology, preclinical development, and other disciplines.
We are disease-area agnostic but hold deep experience across multiple disease areas. We additionally have major technical strengths in areas such as covalent inhibition and protein degradation.
In today’s drug discovery marketplace, Dalriada Drug Discovery provides unique value and a compelling commercial offering. We invite potential clients to visit our newly enhanced website, www.dalriadatx.com, and to connect with us for exploratory conversations.
GTP Bioways CDMO
GTP Bioways is a CDMO offering integrated manufacturing services to support biopharma companies from preclinical to commercial production of their innovative therapies. Our expertise and capabilities cover the manufacturing of biologics (mammalian and microbial processes), antibody-drug-conjugates, and nanodrugs. Drawing on our expertise in solving difficult client problems, we strive to offer a tailored approach, finely tuned to overcome each specific challenge.
www.gtp-bioways.com/@company
GTP Bioways is an expert CDMO offering end-to-end services to help biopharma companies bring their biotherapeutics to market. With expertise spanning both process development and GMP manufacturing for a broad diversity of biomolecules, we can support the most challenging projects. Thanks to our tailored approach and strong expertise, we are perfectly equipped to carry programmes from very early inception all the way to clinic. For more information, please visit www.gtp-bioways.com
Vetter Pharma
Vetter is a globally leading and operating Contract Development and Manufacturing Organization
www.vetter-pharma.com/en/@company
(CDMO) specializing in aseptic production of prefilled drug delivery systems for complex biologics
including syringes, cartridges, and vials both liquid and lyophilized. We do not manufacture own drug
products but rather our role is to support the global supply of our customers' life-changing injectable
medications.
As a strategic manufacturing partner for our customers, we provide skilled support and state-of-theart fill & finish services at every step of the injectable product life cycle – from initial clinical
development and regulatory approval, to successful launch, commercial production, and beyond by
taking advantage of our dedicated clinical manufacturing facilities near Chicago, USA, or Rankweil,
Austria and our headquarter sites in Ravensburg, Germany, for late clinical and commercial
production.
Aragen
Aragen Life Sciences is a leading contract research, development and manufacturing (CRDMO) solutions provider for the life sciences industries worldwide offering end-to-end integrated and standalone solutions for small and large molecules. Established in 2001, we operate through a global network of six sites with a team of 3800+ employees and 450+ PhDs. Our expertise and experience have enabled over 450+ customers in advancing their research programs from discovery through commercialization. Aragen’s innovative mindset, infrastructure, flexible business models have enabled us to serve large pharma or biotech, agrochemical, animal health and performance chemical industries globally.
www.aragen.com/@company
All our facilities conform to stringent regulatory standards. Our infrastructure has a built-up area of 1.2 million square feet, housing chemistry and biology labs, AAALAC-accredited animal houses, analytical labs, formulation development labs, kilo labs, pilot plants and manufacturing facilities. Aragen has been inspected by all the leading regulatory agencies of the world, including USFDA, WHO, PMDA, EDQM and EMEA. For more details, visit www.aragen.com
- Media Supporters
- Organiser
